Fellowship · New Haven, CT
Sponsored by Yale-New Haven Hospital
Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue.
JAMA oncology · 2022 · 303 citations · Kimmie Rabe
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021 · 217 citations · Adebowale Adeniran
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial.
Lancet (London, England) · 2021 · 241 citations · Adebowale Adeniran
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021 · 186 citations · Adebowale Adeniran
The Association of Microaggressions with Depressive Symptoms and Institutional Satisfaction Among a National Cohort of Medical Students.
Journal of general internal medicine · 2022 · 83 citations · Amanda Hernandez
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2023 · 79 citations ·
An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021 · 109 citations · Angelique Levi
Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial.
JAMA oncology · 2024 · 39 citations · Guoping Cai